Oxcarbazepine is the generic name for the anticonvulsant medication originally sold under the brand name Trileptal. It works by stabilizing electrical activity in the brain to prevent seizures.
Oxcarbazepine blocks sodium channels in nerve cells, reducing abnormal electrical activity in the brain. This helps prevent the sudden bursts of electrical activity that cause seizures. Unlike some other anticonvulsants, it doesn't affect neurotransmitter systems like GABA or glutamate.
Oxcarbazepine comes in two forms:
The extended-release form was approved in 2011 to provide more consistent blood levels throughout the day.
Doctors primarily prescribe oxcarbazepine to treat partial seizures in adults and children over 2 years old. It's also used as a monotherapy (single drug treatment) for generalized tonic-clonic seizures in adults.
A less common use is treating bipolar disorder, though it's not FDA-approved for this purpose. Research shows it may help stabilize mood in some patients who don't respond to standard treatments.
Many people confuse oxcarbazepine with carbamazepine, another anticonvulsant. While they're chemically related and have similar uses, oxcarbazepine causes fewer side effects and drug interactions. Unlike carbamazepine, oxcarbazepine doesn't induce liver enzymes that metabolize many other medications.
When I worked in a neurology clinic, we often prescribed oxcarbazepine for patients who couldn't tolerate carbamazepine's side effects. One patient, a 35-year-old woman with partial seizures, experienced severe dizziness on carbamazepine but did well on oxcarbazepine. Her seizure frequency decreased by 70% within three months of switching.